STOCK TITAN

LIFEWAY FOODS REJECTS PROPOSAL FROM DANONE AND ADOPTS LIMITED DURATION SHAREHOLDER RIGHTS PLAN

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Lifeway Foods (NASDAQ: LWAY) has rejected Danone North America's unsolicited proposal to acquire all remaining shares at $25.00 per share, stating it undervalues the company. In response, Lifeway's Board adopted a duration shareholder rights plan effective immediately through November 4, 2025. The plan will distribute one preferred share purchase right per common stock to shareholders of record by November 18, 2024. These rights become exercisable if any entity acquires 20% or more ownership without Board approval. The plan aims to protect shareholders' interests while allowing the Board to consider fair acquisition offers.

Lifeway Foods (NASDAQ: LWAY) ha respinto la proposta non richiesta di Danone North America di acquisire tutte le restanti azioni a 25,00 dollari per azione, affermando che non riflette adeguatamente il valore dell'azienda. In risposta, il Consiglio di Lifeway ha adottato un piano di diritti per gli azionisti che entra in vigore immediatamente fino al 4 novembre 2025. Il piano prevede la distribuzione di un diritto di acquisto di azioni privilegiate per ogni azione comune agli azionisti registrati entro il 18 novembre 2024. Questi diritti diventano esercitabili se qualsiasi ente acquisisce il 20% o più della proprietà senza l'approvazione del Consiglio. L'obiettivo del piano è proteggere gli interessi degli azionisti, consentendo al Consiglio di considerare offerte di acquisizione equa.

Lifeway Foods (NASDAQ: LWAY) ha rechazado la propuesta no solicitada de Danone North America para adquirir todas las acciones restantes a $25.00 por acción, afirmando que subestima el valor de la compañía. En respuesta, la Junta de Lifeway adoptó un plan de derechos de los accionistas que entra en vigor de inmediato y será efectivo hasta el 4 de noviembre de 2025. El plan distribuirá un derecho de compra de acciones preferentes por cada acción común a los accionistas registrados antes del 18 de noviembre de 2024. Estos derechos se podrán ejercer si alguna entidad adquiere el 20% o más de la propiedad sin la aprobación de la Junta. El plan tiene como objetivo proteger los intereses de los accionistas, permitiendo a la Junta considerar ofertas de adquisición justas.

라이프웨이 푸드 (NASDAQ: LWAY)는 다논 북미의 모든 잔여 주식을 주당 $25.00에 인수하겠다는 비공식 제의를 거부하며, 이는 회사 가치를 과소평가한다고 밝혔습니다. 이에 따라 라이프웨이의 이사회는 즉시 발효되며 2025년 11월 4일까지 유효한 주주 권리 계획을 채택했습니다. 이 계획은 2024년 11월 18일까지 기록된 주주에게 보통주당 하나의 우선주 매입 권리를 배부합니다. 이러한 권리는 어떤 기관이 이사회의 승인 없이 20% 이상의 소유권을 취득할 경우 행사할 수 있습니다. 이 계획은 주주들의 이익을 보호하는 것을 목표로 하며, 이사회가 공정한 인수 제안을 고려할 수 있도록 합니다.

Lifeway Foods (NASDAQ: LWAY) a rejeté la proposition non sollicitée de Danone North America d'acquérir toutes les actions restantes à 25,00 $ par action, affirmant que cela sous-estime la valeur de l'entreprise. En réponse, le Conseil de Lifeway a adopté un plan de droits des actionnaires qui prend effet immédiatement et sera valable jusqu'au 4 novembre 2025. Le plan distribuera un droit d'achat d'actions privilégiées pour chaque action ordinaire aux actionnaires inscrits d'ici le 18 novembre 2024. Ces droits deviennent exercables si une entité acquiert 20% ou plus de la propriété sans l'approbation du Conseil. L'objectif du plan est de protéger les intérêts des actionnaires tout en permettant au Conseil d'examiner des offres d'acquisition justes.

Lifeway Foods (NASDAQ: LWAY) hat das unaufgeforderte Angebot von Danone North America abgelehnt, alle verbleibenden Aktien zu einem Preis von 25,00 US-Dollar pro Aktie zu erwerben, und erklärt, dass dies den Wert des Unternehmens nicht angemessen widerspiegelt. Als Antwort hat der Vorstand von Lifeway einen Aktionärsrechteplan angenommen, der sofort in Kraft tritt und bis zum 4. November 2025 gültig ist. Der Plan sieht vor, einem Stammaktieninhaber bis zum 18. November 2024 ein Recht auf den Kauf von Vorzugsaktien zu gewähren. Diese Rechte können ausgeübt werden, wenn eine Partei 20% oder mehr des Eigentums ohne Zustimmung des Vorstands erwirbt. Ziel des Plans ist es, die Interessen der Aktionäre zu schützen und dem Vorstand die Möglichkeit zu geben, faire Übernahmeangebote zu prüfen.

Positive
  • Board's proactive measure to protect shareholder value through rights plan implementation
  • Strong recent financial performance mentioned by management
  • Company maintains strategic focus on market expansion
Negative
  • Potential acquisition offer rejected at $25.00 per share
  • Existing significant ownership position by Danone creates uncertainty

Insights

The rejection of Danone's $25.00 per share acquisition offer and implementation of a poison pill defense strategy represents a significant development for Lifeway Foods. The current proposal values the company at approximately $366 million, but management believes this undervalues their growth potential. The poison pill mechanism, triggered if any entity acquires 20% or more ownership, effectively blocks hostile takeover attempts while maintaining flexibility for board-approved deals.

This defensive move comes amid Lifeway's strong market performance and expanding presence in the probiotics space. The board's confidence in rejecting the offer suggests they see greater long-term value potential, though this could also risk alienating some shareholders who might have welcomed the immediate premium. The one-year duration of the rights plan indicates the board wants to maintain negotiating leverage while keeping options open for future strategic alternatives.

The shareholder rights plan implementation is strategically structured to protect minority shareholders while maintaining board control over any potential change in control. Key features include the 20% ownership trigger threshold and the dilutive mechanism that doubles share rights for non-triggering shareholders. The November 4, 2025 expiration provides a reasonable timeframe for considered strategic alternatives without permanently entrenching management.

The board's fiduciary approach is evident in their engagement of independent advisors Evercore and Sidley Austin LLP, demonstrating proper corporate governance in evaluating the unsolicited offer. The rights plan's structure allows for board-approved transactions, maintaining flexibility for potentially improved offers while protecting against coercive takeover tactics.

MORTON GROVE, Ill., Nov. 5, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ: LWAY) ("Lifeway" or the "Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced that its Board of Directors (the "Board") has rejected the unsolicited proposal made on September 23, 2024 by Danone North America PBC ("Danone") to acquire all the shares of Lifeway that it does not already own for $25.00 per share.

After careful and thorough consideration, conducted in consultation with its independent financial and legal advisors, the Board determined that Danone's opportunistic proposal substantially undervalues Lifeway and is not in the best interests of the Company and its shareholders or other stakeholders. In addition, in response to Danone's proposal and its substantial ownership position in the Company, the Board adopted a limited duration shareholder rights plan, effective immediately (the "Rights Plan").

The Rights Plan is intended to enable all shareholders to realize the full value of their investment in Lifeway. The Rights Plan will reduce the likelihood that Danone gains control of Lifeway through open market accumulation or otherwise without paying all shareholders an appropriate control premium or without providing the Board sufficient time to make informed judgments and take actions that are in the best interests of all of the Company's shareholders and other stakeholders.

The Rights Plan has similar provisions to those of other plans adopted by publicly-held companies in comparable circumstances. Under the Rights Plan, Lifeway will distribute to its shareholders one preferred share purchase right for each outstanding share of Lifeway common stock to shareholders of record at the close of business on November 18, 2024. Initially, these rights will not be exercisable and will trade with, and be represented by, the shares of Lifeway common stock.

Under the Rights Plan, the rights will become exercisable if an entity, person or group acquires beneficial ownership of 20% or more of the outstanding shares of Lifeway common stock in a transaction not approved by the Board or if an entity, person or group that currently beneficially owns 20% or more of the outstanding shares of Lifeway common stock acquires any additional shares. If the rights become exercisable, each right will entitle its holder (other than the person, entity or group triggering the Rights Plan, whose rights will become void and will not be exercisable) to purchase, at the then-current exercise price, additional shares of common stock having a then-current market value of twice the exercise price of the right. Certain synthetic interests in securities created by derivative positions are considered to be ownership of the underlying shares of common stock for purposes of the Rights Plan.

The Rights Plan does not deter any offer to acquire the Company from any party, nor does it preclude Lifeway's Board from considering an offer that is fair and otherwise in the best interests of the Company's shareholders.

Unless earlier redeemed, terminated or exchanged pursuant to the Rights Plan, the rights will expire on November 4, 2025.

Lifeway remains focused on its strategic plan to bring kefir to more households while also expanding into adjacent categories. The Company plans to continue to build on its strong momentum, as evidenced by recent financial results, and creating shareholder value. The Board and management are committed to acting in the best interests of all shareholders and ensuring that they are able to realize the full potential value of their investment.

Further details about the Rights Plan will be contained in a Current Report on Form 8-K to be filed by the Company with the Securities and Exchange Commission.

Evercore is serving as a financial advisor to Lifeway and Sidley Austin LLP is serving as legal counsel to Lifeway.

About Lifeway Foods, Inc.
Lifeway Foods, Inc., which has been recognized as one of Forbes' Best Small Companies, is America's leading supplier of the probiotic, fermented beverage known as kefir. In addition to its line of drinkable kefir, the company also produces a variety of cheeses and a ProBugs line for kids. Lifeway's tart and tangy fermented dairy products are now sold across the United States, Mexico, Ireland, South Africa and France. Learn how Lifeway is good for more than just you at lifewayfoods.com.

Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include all statements that are not historical statements of fact and those regarding our intent, belief or expectations for our business, operations, financial performance or condition. These statements use words such as "continue," "believe," "expect," "anticipate," "plan," "project," "estimate," "outlook," and similar expressions or future or conditional verbs such as "will," "should," "would," "may" and "could." You are cautioned not to rely on these forward-looking statements. These forward-looking statements are made as of the date of this press release, are based on current expectations of future events and thus are inherently subject to a number of risks and uncertainties, many of which involve factors or circumstances beyond Lifeway's control. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from Lifeway's expectations and projections. These risks, uncertainties and other factors include: price competition; the decisions of customers or consumers; the actions of competitors; changes in the pricing of commodities; the effects of government regulation; possible delays in the introduction of new products; customer acceptance of products and services; and other factors discussed in Part I, Item 1A "Risk Factors" of Lifeway's Annual Report on Form 10-K for the fiscal year ended December 31, 2023. Lifeway expressly disclaims any obligation to update any forward-looking statements (including, without limitation, to reflect changed assumptions, the occurrence of anticipated or unanticipated events or new information), except as required by law.

Contacts:
Perceptual Advisors
Dan Tarman
Email: dtarman@perceptualadvisors.com

OR

Longacre Square Partners
Joe Germani / Miller Winston
Email: LWAY@longacresquare.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lifeway-foods-rejects-proposal-from-danone-and-adopts-limited-duration-shareholder-rights-plan-302296092.html

SOURCE Lifeway Foods, Inc.

FAQ

What was Danone's offer price for Lifeway Foods (LWAY) shares?

Danone offered to acquire Lifeway Foods (LWAY) shares at $25.00 per share on September 23, 2024.

When does Lifeway Foods' (LWAY) shareholder rights plan expire?

The shareholder rights plan expires on November 4, 2025, unless earlier redeemed, terminated, or exchanged.

What triggers the rights plan in Lifeway Foods (LWAY)?

The rights become exercisable if an entity acquires 20% or more of outstanding shares without Board approval, or if current 20%+ owners acquire additional shares.

When will Lifeway Foods (LWAY) distribute the preferred share purchase rights?

Lifeway will distribute one preferred share purchase right per common share to shareholders of record by November 18, 2024.

Lifeway Foods Inc

NASDAQ:LWAY

LWAY Rankings

LWAY Latest News

LWAY Stock Data

352.69M
4.68M
68.55%
20.36%
0.92%
Packaged Foods
Dairy Products
Link
United States of America
MORTON GROVE